TrialEuropean journal of cancer (Oxford, England : 1990)2020

Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial.

David A Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.